Anti-rejection regimens currently in use are broad immunosuppressive agents that make patients susceptible to infections. By using specific antibodies, it may be possible to just block the inflammation that leads to rejection but leave anti-microbial immunity intact.
Pre-surgical antibody treatment might prevent heart transplant rejection
- Post author:
- Post published:August 13, 2024
- Post category:News Feed
- Post comments:0 Comments